Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of EPHA5 in lung adenocarcinoma is associated with lymph node metastasis and EGFR mutation.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica - 1 Jun 2022

Liu Chengying, He Yan, Feng Xiao, Li Jie, Wang Jiandong

Abstract excerpt

EPHA5 is a member of the Eph family of tyrosine kinase receptors, which affect carcinogenesis. The expression level of the EPHA5 receptor in a set of lung adenocarcinoma tissue samples was checked using immunohistochemistry. The relationship between EPHA5 expression and clinicopathological parameters, and epidermal growth factor receptor (EGFR) and Braf mutations were analyzed. We also checked the expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Lymphatic Metastasis

Share to Mutation

Source

Identifiers

PMID: 35332588
DOI: 10.1111/apm.13222

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of EPHA5 in lung adenocarcinoma is associated with lymph node metastasis and EGFR mutation.PMID 35332588Read ↗

EPHA5 mutation impairs natural killer cell-mediated cytotoxicity against non-small lung cancer cells and promotes cancer cell migration and invasion.Semantic proximity Read ↗

EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma.Semantic proximity Read ↗

Receptor Tyrosine Kinase EphA5 Is a Functional Molecular Target in Human Lung CancerSemantic proximity Read ↗

EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma.Semantic proximity Read ↗

KLF5 facilitates lung adenocarcinoma metastasis via regulating the epithelial-mesenchymal transition pathway through RHPN2Semantic proximity Read ↗

Epidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer Cells.Semantic proximity Read ↗

Interactions between EGFR and EphA2 promote tumorigenesis through the action of Ephexin1.Semantic proximity Read ↗

Oncogenic EFNA4 amplification promotes lung adenocarcinoma lymph node metastasisSemantic proximity Read ↗

EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.Semantic proximity Read ↗

CEACAM5 stimulates the progression of non-small-cell lung cancer by promoting cell proliferation and migrationSemantic proximity Read ↗

ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2.Semantic proximity Read ↗

Molecular Characteristics and Prognostic Role of EPHA2 in Human Tumors via Pan-cancer AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.